Bofill Rodriguez M, Dias S, Jordan V et al. Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis. Cochrane Database Syst Rev 2022; (5): CD013180.
Bofill Rodriguez M, Lethaby A, Farquhar C. Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 2019; (9): CD000400.
Bofill Rodriguez M, Lethaby A, Fergusson RJ. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev 2021; (2): CD000329.
Bofill Rodriguez M, Lethaby A, Jordan V. Progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 2020; (6): CD002126.
Bofill Rodriguez M, Lethaby A, Low C, Cameron IT. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev 2019; (8): CD001016.
Bryant-Smith AC, Lethaby A, Farquhar C, Hickey M. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev 2018; (4): CD000249.
Chen S, Liu J, Peng S, Zheng Y. LNG-IUS vs. medical treatments for women with heavy menstrual bleeding: A systematic review and meta-analysis. Front Med (Lausanne) 2022; 9: 948709.
Christelle K, Norhayati MN, Jaafar SH. Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use. Cochrane Database Syst Rev 2022; (8): CD006034.
Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). Hormonelle Empfängnisverhütung (S3-Leitlinie, in Überarbeitung). AWMF-Registernr.: 015-015. 2020.
Deutsche Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). Indikation und Methodik der Hysterektomie bei benignen Erkrankungen (S3-Leitlinie). AWMF-Registernr.: 015-070. 2015.
Fergusson RJ, Bofill Rodriguez M, Lethaby A, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev 2019; (8): CD000329.
Hartmann KE, Fonnesbeck C, Surawicz T et al. Management of Uterine Fibroids. (AHRQ Comparative Effectiveness Reviews; Band 195). 2017.
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). High frequency ablation of the endometrium using a mesh electrode in patients with menorrhagia: Final report; Commission N20-06. 2021.
Institute for Quality and Efficiency in Health Care (IQWiG, Germany). Myomectomy versus no treatment - Evidence report for the S3 guideline on diagnosis and treatment of benign diseases of the uterus. Commission V21-08B. 2023.
Kohn JR, Shamshirsaz AA, Popek E et al. Pregnancy after endometrial ablation: a systematic review. BJOG 2018; 125(1): 43-53.
Lethaby A, Wise MR, Weterings MA et al. Combined hormonal contraceptives for heavy menstrual bleeding. Cochrane Database Syst Rev 2019; (2): CD000154.
Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev 2016; (1): CD003855.
IQWiG health information is written with the aim of helping people understand the advantages and disadvantages of the main treatment options and health care services.
Because IQWiG is a German institute, some of the information provided here is specific to the German health care system. The suitability of any of the described options in an individual case can be determined by talking to a doctor. informedhealth.org can provide support for talks with doctors and other medical professionals, but cannot replace them. We do not offer individual consultations.
Our information is based on the results of good-quality studies. It is written by a team of health care professionals, scientists and editors, and reviewed by external experts. You can find a detailed description of how our health information is produced and updated in our methods.